ALIF-B AddLife AB (publ)
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis. It offers products and solutions, including analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical services; and in the areas of microbiology, clinical chemistry, coagulation, molecular biology, research, immunology, point-of-care testing, veterinary diagnostics, as well as in the food industry. This segment also provides training programs for its customers. The Medtech segment provides medical device products for surgery, orthopaedics, critical care, endoscopy, wound care, healthcare IT, ophthalmology, home adaptation, and technical aids, as well as surgical procedures, welfare technology, and assistive devices for the elderly and disabled. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, Poland, Austria, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.…
Industry Peers
Medical Instruments & SuppliesKey Statistics
About AddLife (STO: ALIF-B)
›
AddLife (STO: ALIF-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 2,428 employees.
The shares were at 176.60 SEK on 20 November 2026, down 4.9% over 52 weeks. Its 52-week range is 130.20 SEK to 192.80 SEK: the price is 8.4% below the high and 35.6% above the low.
At a market capitalisation of 21.52B SEK, it trades at 33.5 times trailing earnings and 55.5 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 48.3, a discount of 31% for ALIF-B. It pays a dividend yielding 0.84% (it pays out 28% of its earnings), against a median of 0.92% among the dividend payers in that peer group.
AddLife reports return on equity of 10.3%, an operating margin of 8.9% and revenue up 7.0% year over year.
Its debt exceeds its cash by 4.66B SEK, a debt-to-equity ratio of 0.88. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 4 analysts cover the stock; their mean price target of 205.75 SEK is 16.5% above the current price. The next earnings report is expected on 3 February 2027.